MENLO PARK, Calif. (AP) _ Corcept Therapeutics Inc. (CORT) on Thursday reported first-quarter profit of $22.8 million.On a per-share basis, the Menlo Park, California-based company said it had net income of 20 cents.The results missed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for earnings of 23 cents per share.The drug developer posted revenue of $93.7 million in the period._____This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CORT at https://www.zacks.com/ap/CORT